Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Common Stock | 63.4K | $225K | $3.54 | Mar 6, 2023 | Direct |
Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 55.8K | Mar 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARQT | Arcutis Biotherapeutics, Inc. | Mar 6, 2023 | 1 | -$12.7K | 4 | Mar 8, 2023 | Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Mar 2, 2023 | 2 | $0 | 4 | Mar 6, 2023 | Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Feb 28, 2023 | 3 | -$37.8K | 4 | Mar 2, 2023 | Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Mar 3, 2022 | 4 | -$17.2K | 4 | Mar 7, 2022 | Chief Commercial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Mar 1, 2022 | 1 | -$16.6K | 4 | Mar 3, 2022 | Chief Commercial Officer |